A Phase 1, Open-label, Randomized, Crossover Study in 20 Healthy Subjects to Investigate the Potential Pharmacokinetic Interaction Between Telaprevir and Raltegravir, Both at Steady-state

Trial Profile

A Phase 1, Open-label, Randomized, Crossover Study in 20 Healthy Subjects to Investigate the Potential Pharmacokinetic Interaction Between Telaprevir and Raltegravir, Both at Steady-state

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2012

At a glance

  • Drugs Raltegravir; Telaprevir
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacokinetics
  • Sponsors Janssen Infectious Diseases BVBA
  • Most Recent Events

    • 04 Nov 2011 Actual initiation date changed from Jan 2011 to Dec 2010 as reported by ClinicalTrials.gov.
    • 02 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top